Healthcor Management LP Has Cut Edwards Lifesciences (EW) Holding by $93.90 Million; Stock Rose; Consonance Capital Management LP Continues to Hold Holding in Retrophin (RTRX)

February 12, 2018 - By Maria Brooks

Arthur B Cohen decreased its stake in Edwards Lifesciences Corp (EW) by 71.79% based on its latest 2017Q3 regulatory filing with the SEC. Healthcor Management Lp sold 861,510 shares as the company’s stock rose 25.80% with the market. The hedge fund run by Arthur B Cohen held 338,490 shares of the industrial specialties company at the end of 2017Q3, valued at $37.00 million, down from 1.20 million at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Edwards Lifesciences Corp for a number of months, seems to be less bullish one the $26.94B market cap company. The stock increased 0.80% or $1.01 during the last trading session, reaching $127.28. About 846,704 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 15.41% since February 12, 2017 and is uptrending. It has underperformed by 1.29% the S&P500.

Mitchell Blutt increased its stake in Retrophin Inc (RTRX) by 43.76% based on its latest 2017Q3 regulatory filing with the SEC. Consonance Capital Management Lp bought 1.07 million shares as the company’s stock declined 17.61% while stock markets rallied. The hedge fund run by Mitchell Blutt held 3.51 million shares of the health care company at the end of 2017Q3, valued at $87.25M, up from 2.44 million at the end of the previous reported quarter. Consonance Capital Management Lp who had been investing in Retrophin Inc for a number of months, seems to be bullish on the $829.37 million market cap company. The stock decreased 0.61% or $0.13 during the last trading session, reaching $21.1. About 327,713 shares traded or 51.44% up from the average. Retrophin, Inc. (NASDAQ:RTRX) has risen 4.93% since February 12, 2017 and is uptrending. It has underperformed by 11.77% the S&P500.

Among 4 analysts covering Retrophin (NASDAQ:RTRX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Retrophin had 7 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Retrophin, Inc. (NASDAQ:RTRX) has “Buy” rating given on Friday, October 6 by BMO Capital Markets. The firm has “Outperform” rating given on Tuesday, April 12 by BMO Capital Markets. The stock of Retrophin, Inc. (NASDAQ:RTRX) has “Buy” rating given on Tuesday, November 7 by BMO Capital Markets. JMP Securities initiated the stock with “Mkt Outperform” rating in Monday, November 2 report. The firm has “Buy” rating given on Wednesday, August 12 by Zacks.

Consonance Capital Management Lp, which manages about $513.80M and $904.16M US Long portfolio, decreased its stake in Advanced Accelerator Applic by 978,572 shares to 890,935 shares, valued at $60.25 million in 2017Q3, according to the filing. It also reduced its holding in Keryx Biopharmaceuticals Inc (NASDAQ:KERX) by 1.78 million shares in the quarter, leaving it with 5.23M shares, and cut its stake in Globus Med Inc (NYSE:GMED).

Investors sentiment increased to 1.62 in Q3 2017. Its up 0.46, from 1.16 in 2017Q2. It is positive, as 12 investors sold RTRX shares while 25 reduced holdings. 20 funds opened positions while 40 raised stakes. 40.07 million shares or 1.15% more from 39.61 million shares in 2017Q2 were reported. New York State Common Retirement Fund invested in 0% or 40,900 shares. Dimensional Fund Advsrs Ltd Partnership holds 0.01% in Retrophin, Inc. (NASDAQ:RTRX) or 896,815 shares. Metropolitan Life Ins Ny owns 24,765 shares for 0% of their portfolio. 10,796 were reported by Public Employees Retirement Association Of Colorado. The New York-based Spark Investment Mgmt Limited Liability Company has invested 0.39% in Retrophin, Inc. (NASDAQ:RTRX). Voya Invest Mgmt Ltd Limited Liability Company has 0% invested in Retrophin, Inc. (NASDAQ:RTRX) for 17,905 shares. Tiaa Cref Management Ltd, New York-based fund reported 652,052 shares. Boston Advsr Limited Liability Corp has 208,890 shares for 0.12% of their portfolio. Financial Bank Of America Corp De reported 166,046 shares or 0% of all its holdings. State Bank Of Montreal Can stated it has 0% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX). Gsa Prtn Limited Liability Partnership holds 0.02% or 11,700 shares in its portfolio. Price T Rowe Assoc Inc Md reported 0% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX). Trexquant Inv Limited Partnership owns 8,154 shares. Moreover, Rock Springs Cap Limited Partnership has 0.46% invested in Retrophin, Inc. (NASDAQ:RTRX). Arrowstreet Partnership has 0% invested in Retrophin, Inc. (NASDAQ:RTRX).

Since August 16, 2017, it had 0 buys, and 1 sale for $22,646 activity. McFarlane Neil F. sold $31,005 worth of stock or 1,378 shares.

Healthcor Management Lp, which manages about $3.20B and $2.98 billion US Long portfolio, upped its stake in Unitedhealth Group Inc (NYSE:UNH) by 279,890 shares to 382,990 shares, valued at $75.01M in 2017Q3, according to the filing. It also increased its holding in Boston Scientific Corp (NYSE:BSX) by 233,220 shares in the quarter, for a total of 687,170 shares, and has risen its stake in Hill Rom Hldgs Inc (NYSE:HRC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Maria Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: